Metabolic Health
FDA-Cleared Glucose Monitors Outperform Non-Approved Devices for Diabetes Care
FDA-integrated CGMs provide superior accuracy and safety compared to non-approved devices flooding global markets.
Research Paper
Apr 3, 2026 0
Diabetes
290 articles in this topic
Metabolic Health
GLP-1 Drugs Like Ozempic Linked to Gallstones and Acid Reflux in Major Review
Meta-analysis of 106,395 patients reveals GLP-1 receptor agonists increase risk of gallstones by 46% and GERD by 119%.
Research Paper
Apr 3, 2026 0
Metabolic Health
GLP-1 Drugs Fight Inflammation Beyond Weight Loss in Obesity and Diabetes
New research reveals how obesity triggers chronic inflammation and how GLP-1 medications provide anti-inflammatory benefits independent of weight loss.
Research Paper
Apr 3, 2026 0
Metabolic Health
GLP-1 Medications Transform Obesity Treatment Through Novel Mechanisms
New research explores how GLP-1-based drugs like Ozempic and Wegovy work to treat obesity beyond simple appetite suppression.
Research Paper
Apr 3, 2026 0
Metabolic Health
Circadian Clock Controls Fat Cell Energy Production to Prevent Metabolic Disease
Researchers discover how disrupted circadian rhythms in fat cells impair mitochondrial function, leading to metabolic syndrome.
Research Paper
Apr 2, 2026 0
Metabolic Health
AI Predicts Type 2 Diabetes Subtypes Using Continuous Glucose Monitoring Data
Machine learning analyzes glucose patterns to identify distinct metabolic subphenotypes in type 2 diabetes patients.
Research Paper
Apr 2, 2026 0
Metabolic Health
DunedinPACE Epigenetic Clock Predicts Metabolic Syndrome 7 Years Before Onset
New study shows DunedinPACE aging biomarker can predict who will develop metabolic syndrome years in advance, outperforming other epigenetic clocks.
Research Paper
Apr 2, 2026 0
Metabolic Health
New Guidelines for GLP-1 Drugs During Surgery Address Safety Concerns
Expert consensus provides updated recommendations for managing popular weight-loss medications before and after surgery.
Research Paper
Apr 2, 2026 0
Metabolic Health
How GLP-1 Drugs Like Ozempic Actually Cause Weight Loss Through Brain and Body
New review explains the dual mechanisms behind GLP-1 receptor agonists' dramatic weight loss effects in both central and peripheral systems.
Research Paper
Apr 2, 2026 0
Metabolic Health
GLP-1 Weight Loss Drugs Lead to Significant Weight Regain After Stopping
Meta-analysis reveals patients regain substantial weight after discontinuing semaglutide, tirzepatide, and liraglutide therapy.
Research Paper
Apr 2, 2026 0
Metabolic Health
Common Food Additive Maltol Linked to Diabetic Bone Fractures
New research reveals how maltol, a widely used food flavoring, may weaken bones in diabetic patients by disrupting bone remodeling.
Research Paper
Apr 2, 2026 0
Metabolic Health
High-Fat Diets Accelerate Brain Aging Through Multiple Pathways
New review reveals how saturated fat-rich diets trigger neuroinflammation and cognitive decline, but offers actionable prevention strategies.
Research Paper
Mar 30, 2026 4